---
figid: PMC8303312__jpm-11-00652-g003
figtitle: Investigational Drug Treatments for Triple-Negative Breast Cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8303312
filename: jpm-11-00652-g003.jpg
figlink: /pmc/articles/PMC8303312/figure/jpm-11-00652-f003/
number: F3
caption: PI3K/Akt/mTOR pathway as a therapeutic target against triple-negative breast
  cancer.
papertitle: Investigational Drug Treatments for Triple-Negative Breast Cancer.
reftext: Christos Damaskos, et al. J Pers Med. 2021 Jul;11(7):652.
year: '2021'
doi: 10.3390/jpm11070652
journal_title: Journal of Personalized Medicine
journal_nlm_ta: J Pers Med
publisher_name: MDPI
keywords: novel therapeutic strategies | immunotherapy | targeted therapies | PI3kb/mTOR
  inhibitors | PARP inhibitors | histone deacetylase inhibitors
automl_pathway: 0.8771412
figid_alias: PMC8303312__F3
figtype: Figure
redirect_from: /figures/PMC8303312__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8303312__jpm-11-00652-g003.html
  '@type': Dataset
  description: PI3K/Akt/mTOR pathway as a therapeutic target against triple-negative
    breast cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - PCK1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Mtor
  - Tor
  - Akt
---
